US693094A
(en)
|
1900-08-13 |
1902-02-11 |
Hall Signal Co |
Signal and signaling-circuit.
|
US2457820A
(en)
|
1945-12-27 |
1949-01-04 |
Merck & Co Inc |
Amino acid solution and process for preparing the same
|
US3012924A
(en)
|
1956-12-17 |
1961-12-12 |
Libbey Owens Ford Glass Co |
Electrically conducting unit
|
GB1034358A
(en)
|
1963-05-01 |
1966-06-29 |
Chugai Pharmaceutical Co Ltd |
Body-protein-biosynthesis promoting composition
|
US3832465A
(en)
|
1971-12-09 |
1974-08-27 |
H Ghadimi |
Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
|
US3988466A
(en)
|
1973-06-01 |
1976-10-26 |
Kyowa Hakko Kogyo Co., Ltd. |
Prevention of gastric lesions
|
US3950529A
(en)
|
1975-02-03 |
1976-04-13 |
Massachusetts General Hospital |
Amino acid formulations for patients with liver disease and method of using same
|
JPS5535049A
(en)
|
1978-09-04 |
1980-03-11 |
Otsuka Pharmaceut Factory Inc |
Amino acid transfusion for cancerous patient
|
DE2906034C2
(de)
|
1979-02-16 |
1985-03-28 |
Maggi AG, Kempttal |
Verfahren zur Gewinnung von L-Leucin, L-Phenylalanin, L-Tyrosin, L-Cystin und von Gemischen aus L-Leucin und L-Isoleucin
|
CA1184499A
(en)
|
1981-06-29 |
1985-03-26 |
David C. Madsen |
Nutritional composition for management of hepatic failure
|
US4898879A
(en)
|
1981-06-29 |
1990-02-06 |
Baxter International Inc. |
Nurtitional composition for management of hepatic failure
|
JPS58126767A
(ja)
|
1982-01-22 |
1983-07-28 |
Ajinomoto Co Inc |
肝臓病患者用栄養組成物
|
US5298493A
(en)
|
1983-04-20 |
1994-03-29 |
Clintec Nutrition Co. |
Compound for use in dietetics, reanimation and therapeutics containing protein fractions based on three types of minipeptides
|
CH658165A5
(fr)
|
1984-01-04 |
1986-10-31 |
Nestle Sa |
Produit alimentaire efficace dans le traitement de la lepre.
|
US5034377A
(en)
|
1984-11-19 |
1991-07-23 |
Montefiore Hospital Association Of Western Pennsylvania |
Aqueous nutrient compositions comprising oligopeptides
|
JPS61186320A
(ja)
*
|
1985-02-12 |
1986-08-20 |
Morishita Seiyaku Kk |
アミノ酸製剤
|
US4871550A
(en)
|
1986-09-05 |
1989-10-03 |
Millman Phillip L |
Nutrient composition for athletes and method of making and using the same
|
FR2618331B1
(fr)
|
1987-07-23 |
1991-10-04 |
Synthelabo |
Compositions pharmaceutiques utiles pour le traitement de l'uremie
|
US5028622A
(en)
|
1988-05-06 |
1991-07-02 |
Ajinomoto Company, Inc. |
Administration of amino acids as treatment for neurodegenerative disorders
|
US5576351A
(en)
|
1989-12-29 |
1996-11-19 |
Mcgaw, Inc. |
Use of arginine as an immunostimulator
|
CA2054358C
(en)
|
1990-11-01 |
2004-12-28 |
Candis D. Kvamme |
High acid nutritional formulations
|
US5106836A
(en)
|
1991-02-22 |
1992-04-21 |
Clintec Nutrition Co. |
Enteral diet
|
US5977073A
(en)
|
1991-06-06 |
1999-11-02 |
Life Sciences' Technologies, Inc. |
Nutrient composition for treatment of immune disorders
|
US5780039A
(en)
|
1992-04-23 |
1998-07-14 |
Novartis Nutrition Ag |
Orally-ingestible nutrition compositions having improved palatability
|
US5229136A
(en)
|
1992-05-21 |
1993-07-20 |
Clintec Nutrition Co. |
Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
|
US5276018A
(en)
|
1992-07-17 |
1994-01-04 |
Brigham And Women's Hospital |
Composition comprising amino acids and methods for decreasing muscle breakdown
|
DE4229166A1
(de)
|
1992-09-01 |
1994-03-03 |
Deutsches Krebsforsch |
Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
|
US5356873A
(en)
|
1992-11-05 |
1994-10-18 |
Clintec Nutrition Co. |
Method for providing nutritional requirements to patients having a chronic inflammation reaction
|
DE69331528T2
(de)
|
1992-12-23 |
2002-10-31 |
Abbott Laboratories, Abbott Park |
Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
|
US5348979A
(en)
*
|
1992-12-23 |
1994-09-20 |
Iowa State University Research Foundation Inc. |
Method of promoting nitrogen retention in humans
|
US5571783A
(en)
|
1993-03-09 |
1996-11-05 |
Clintec Nutrition Company |
Composition and method for treating patients with hepatic disease
|
US5891459A
(en)
|
1993-06-11 |
1999-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
|
WO1995004529A1
(en)
|
1993-08-10 |
1995-02-16 |
Musashi Pty. Ltd. |
Composition for treatment of hangovers
|
US5438042B1
(en)
|
1993-10-08 |
1997-08-26 |
Sandoz Nutrition Ltd |
Enteral nutritional composition having amino acid profile
|
AU682894B2
(en)
|
1993-10-28 |
1997-10-23 |
Institut National De La Recherche Agronomique |
Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
|
US5378722A
(en)
|
1993-12-03 |
1995-01-03 |
Clintec Nutrition Co. |
Nutritional compositions for management of nitrogen metabolism
|
US5723446A
(en)
|
1993-12-23 |
1998-03-03 |
Nestec Ltd. |
Enteral formulation designed for optimized nutrient absorption and wound healing
|
US5714472A
(en)
|
1993-12-23 |
1998-02-03 |
Nestec Ltd. |
Enternal formulation designed for optimized nutrient absorption and wound healing
|
GB9403935D0
(en)
|
1994-03-01 |
1994-04-20 |
Sandoz Nutrition Ltd |
Improvements in or relating to organic compounds
|
US5719133A
(en)
|
1994-09-21 |
1998-02-17 |
Novartis Nutrition Ag |
Adolescent dietary composition
|
IT1275434B
(it)
|
1995-05-19 |
1997-08-07 |
Farmila Farma Milano |
Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
|
US5728678A
(en)
|
1995-06-06 |
1998-03-17 |
Nestec Ltd. |
Method and composition for providing nutrition to a renal failure patient
|
JP4280310B2
(ja)
|
1995-08-10 |
2009-06-17 |
佐々木化学工業株式会社 |
アミノ酸組成剤
|
US5733884A
(en)
|
1995-11-07 |
1998-03-31 |
Nestec Ltd. |
Enteral formulation designed for optimized wound healing
|
US6087398A
(en)
|
1996-03-01 |
2000-07-11 |
South Alabama Medical Science Foundation |
Sickle cell anemia treatment
|
US5716926A
(en)
|
1996-07-26 |
1998-02-10 |
Paxton K. Beale |
Composition of pyruvate and protein and method for increasing protein concentration in a mammal
|
US6096785A
(en)
|
1996-07-30 |
2000-08-01 |
Novartis Nutrition Ag |
Amino acid compositions and use thereof in treating renal dysfunction
|
JPH1053521A
(ja)
|
1996-08-12 |
1998-02-24 |
Kagaku Gijutsu Shinko Jigyodan |
脳内グルタミン酸の活性抑制剤および活性増強剤
|
US6544260B1
(en)
|
1996-08-20 |
2003-04-08 |
Oratec Interventions, Inc. |
Method for treating tissue in arthroscopic environment using precooling and apparatus for same
|
IT1289754B1
(it)
|
1996-12-16 |
1998-10-16 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi
|
US6013273A
(en)
|
1997-01-27 |
2000-01-11 |
Novartis Nutrition Ag |
Treatment of endotoxic shock
|
US5817329A
(en)
|
1997-02-28 |
1998-10-06 |
Gardiner; Paul T. |
Nutritional supplement for increased muscle size and strength for body builders
|
US5849335A
(en)
|
1997-06-02 |
1998-12-15 |
Nestec S.A. |
Composition and method for providing glutamine
|
EP1123013A1
(en)
|
1997-06-02 |
2001-08-16 |
Société des Produits Nestlé S.A. |
Product and method for providing glutamine
|
US6281244B1
(en)
|
1997-06-05 |
2001-08-28 |
Novartis Nutrition Ag |
Therapeutic use for glycine
|
CA2239582C
(en)
|
1997-06-05 |
2008-04-22 |
Novartis Nutrition Ag |
A new therapeutic use for glycine
|
EP0891719A1
(en)
|
1997-07-14 |
1999-01-20 |
N.V. Nutricia |
Nutritional composition containing methionine
|
IT1294227B1
(it)
|
1997-08-01 |
1999-03-24 |
Sigma Tau Ind Farmaceuti |
Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
|
TW473387B
(en)
|
1997-09-30 |
2002-01-21 |
Chugai Pharmaceutical Co Ltd |
Pharmaceutical or food compositions for treating hepatic diseases or improving liver functions
|
US6288116B1
(en)
|
1998-05-13 |
2001-09-11 |
Novartis Nutrition Ag |
Method of administration of a nutritional product to a person having renal failure
|
US6203820B1
(en)
|
1998-05-28 |
2001-03-20 |
Brice E. Vickery |
Compositions and methods for enhancing protein anabolism and detoxification
|
US6103748A
(en)
|
1998-06-19 |
2000-08-15 |
Bryan; Thomas B. |
Method of treating an autoimmune disorder
|
US6031000A
(en)
|
1998-06-23 |
2000-02-29 |
Iowa State University Research Foundation, Inc. |
Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
|
JP2000072669A
(ja)
|
1998-08-24 |
2000-03-07 |
Inst Of Physical & Chemical Res |
アミノ酸・糖組成物
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
US20010041187A1
(en)
|
1998-10-20 |
2001-11-15 |
Carl W Hastings |
Performance-enhancing dietary supplement
|
EP1004302A3
(en)
|
1998-10-29 |
2003-06-04 |
Ajinomoto Co., Inc. |
Immunomodulator
|
US6051236A
(en)
|
1998-11-12 |
2000-04-18 |
Pacifichealth Laboratories, Inc. |
Composition for optimizing muscle performance during exercise
|
US6143786A
(en)
|
1999-02-02 |
2000-11-07 |
Novartis Nutrition Ag |
Oral arginine and insulin secretion
|
US6241996B1
(en)
|
1999-04-09 |
2001-06-05 |
Novartis Nutrition Ag |
Liquid soy nutritional products
|
US6346264B1
(en)
|
1999-04-27 |
2002-02-12 |
International Health Products And Services Ltd. |
Supplement for restoring growth hormone levels
|
AU8003800A
(en)
|
1999-10-08 |
2001-04-23 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
GB9929497D0
(en)
|
1999-12-14 |
2000-02-09 |
Vitaflo Limited |
Improved amino acid mixtures for the treatment and/or management of certain diseases
|
CA2399500A1
(en)
*
|
2000-02-01 |
2001-08-09 |
Muscletech Research And Development Inc. |
Alpha lipoic acid based food supplement for increasing lean muscle mass and strength
|
US6833350B2
(en)
|
2000-02-04 |
2004-12-21 |
Nestec S.A. |
Method for maintaining or improving the synthesis of mucins
|
US6521591B1
(en)
|
2000-02-10 |
2003-02-18 |
N.V. Nutricia |
Pharmaceutical composition for muscular anabolism
|
GB0009056D0
(en)
|
2000-04-12 |
2000-05-31 |
Nestle Sa |
Composition comprising free amino acids
|
EP1276392A2
(en)
|
2000-04-18 |
2003-01-22 |
Société des Produits Nestlé S.A. |
Nutritional modules
|
US6391332B1
(en)
|
2000-04-20 |
2002-05-21 |
Baxter International, Inc. |
Therapeutic micronutrient composition for severe trauma, burns and critical illness
|
US20030187049A1
(en)
|
2000-07-04 |
2003-10-02 |
Dioguardi Francesco Saverio |
Compositions based on aminoacids, suitable for improving muscle performance
|
IT1320783B1
(it)
|
2000-07-04 |
2003-12-10 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.
|
IT1320782B1
(it)
|
2000-07-04 |
2003-12-10 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
|
US6417293B1
(en)
|
2000-12-04 |
2002-07-09 |
Dow Corning Corporation |
Thermoplastic silicone elastomers formed from polyester resins
|
DE10060819A1
(de)
|
2000-12-07 |
2002-06-13 |
Cognis Deutschland Gmbh |
Verwendung von Polyetheramin-Derivaten zur dauerhaften Verbesserung der Klebstoff- und/oder Beschichtungs-Kompatibilität von Polyethylen-basierten Formkörpern, Fasern und Folien
|
DE10060818A1
(de)
|
2000-12-07 |
2002-06-13 |
Cognis Deutschland Gmbh |
Verwendung von Polyetheraminen zur dauerhaften Verbesserung der Klebstoff- und/oder Beschichtungs-Kompatibilität von Polyethylen-basierten Formkörpern, Fasern und Folien
|
WO2002069964A1
(en)
|
2001-03-05 |
2002-09-12 |
Ernest Stephen P |
Enteral formulation
|
ATE441409T1
(de)
|
2001-03-15 |
2009-09-15 |
Riken |
Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber
|
US20020193342A1
(en)
|
2001-05-09 |
2002-12-19 |
Hamman John P. |
Modifying undesirable tastes
|
ITTO20010580A1
(it)
|
2001-06-15 |
2002-12-15 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
|
US6864230B2
(en)
|
2001-07-31 |
2005-03-08 |
Novartis Nutrition Ag |
Glutamine rich dietary composition
|
WO2003055481A1
(fr)
|
2001-12-25 |
2003-07-10 |
Ajinomoto Co., Inc. |
Inhibiteurs de fibrose des organes
|
WO2003061639A2
(en)
|
2002-01-25 |
2003-07-31 |
Diamedica Inc. |
Use of glutathione synthesis stimulating compounds in reducing insulin resistance
|
JP2003238401A
(ja)
|
2002-02-20 |
2003-08-27 |
Ajinomoto Co Inc |
疾患の治療、改善又は予防用医薬品及び飲食品
|
US20050176827A1
(en)
|
2002-05-10 |
2005-08-11 |
Lee Steve S. |
Compositions and methods for glycogen synthesis
|
US7338675B2
(en)
|
2002-05-10 |
2008-03-04 |
Tsi Health Sciences, Inc. |
Fenugreek seed bio-active compositions and methods for extracting same
|
ES2524000T3
(es)
|
2002-06-05 |
2014-12-03 |
Teva Czech Industries S.R.O. |
Reducción de la reticulación de la gelatina
|
WO2004019928A1
(ja)
|
2002-08-30 |
2004-03-11 |
Ajinomoto Co., Inc. |
肝疾患治療剤
|
US20040087490A1
(en)
|
2002-09-20 |
2004-05-06 |
Troup John P. |
Nutritional compositions
|
US20040057983A1
(en)
|
2002-09-25 |
2004-03-25 |
David Schmidt |
Biomolecular wearable apparatus
|
US7037522B2
(en)
|
2002-09-27 |
2006-05-02 |
Western Holdings, L.L.C. |
Nocturnal muscle enhancing composition and method
|
JP2004123564A
(ja)
|
2002-09-30 |
2004-04-22 |
Inst Of Physical & Chemical Res |
中枢機能改善用アミノ酸組成物
|
JP2004182705A
(ja)
|
2002-10-11 |
2004-07-02 |
Yasutoshi Koga |
ミトコンドリア機能異常に起因する疾患における臨床症状発現の予防・治療用組成物
|
US7547450B2
(en)
|
2002-10-24 |
2009-06-16 |
Nestec Ltd. |
Senior feline food
|
US8093292B2
(en)
|
2002-11-22 |
2012-01-10 |
Bionexus, Ltd. |
Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
|
US7288570B2
(en)
|
2002-12-20 |
2007-10-30 |
Nutricia N.V. |
Stimulation of in vivo production of proteins
|
US20040120983A1
(en)
|
2002-12-23 |
2004-06-24 |
Philip Connolly |
Nutritional supplement
|
AU2003296176A1
(en)
|
2002-12-26 |
2004-07-22 |
Ajinomoto Co., Inc. |
Inhibitor for liver cancer onset and progress
|
JP4989836B2
(ja)
|
2002-12-26 |
2012-08-01 |
大塚製薬株式会社 |
経口栄養剤
|
MXPA05009933A
(es)
|
2003-03-18 |
2005-11-04 |
Novartis Ag |
Composiciones que comprenden acidos grasos y aminoacidos.
|
US20040213838A1
(en)
|
2003-04-24 |
2004-10-28 |
Mazer Terrence B. |
Medical food tablets containing free amino acids
|
JP4528925B2
(ja)
|
2003-05-30 |
2010-08-25 |
独立行政法人理化学研究所 |
アミノ酸組成物及び補液
|
EP2382874A1
(en)
|
2003-06-23 |
2011-11-02 |
Nestec S.A. |
Amino acid supplementation for a healthy microbiota ecosystem
|
JP2005027524A
(ja)
|
2003-07-08 |
2005-02-03 |
Ajinomoto Co Inc |
経口アミノ酸組成物
|
WO2005017094A2
(en)
|
2003-08-19 |
2005-02-24 |
Bioadvantex Pharma Inc. |
N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency
|
ITTO20030789A1
(it)
|
2003-10-07 |
2005-04-08 |
Professional Dietetics Srl |
Composizione a base di amino acidi per il trattamento
|
CA2542652C
(en)
|
2003-10-16 |
2014-05-13 |
Nestec S.A. |
Nutritional composition against side effects of chemotherapy or radiotherapy
|
EP1685833A1
(en)
|
2003-11-21 |
2006-08-02 |
Ajinomoto Co., Inc. |
Remedy for diabetes
|
ES2550608T3
(es)
|
2003-12-20 |
2015-11-11 |
Nestec S.A. |
Composición nutritiva para la curación de las heridas
|
KR20060124732A
(ko)
|
2004-01-28 |
2006-12-05 |
아지노모토 가부시키가이샤 |
국소 뇌혈류 저하에 따른 신경계 장해의 예방 또는 치료용의약 조성물
|
JP4568870B2
(ja)
|
2004-02-27 |
2010-10-27 |
独立行政法人農業・食品産業技術総合研究機構 |
遊離アミノ酸を富化した食品素材及びその製造法
|
US20050233013A1
(en)
*
|
2004-03-02 |
2005-10-20 |
Lee Steve S |
Methods for enhancing the transport of glucose for balancing blood sugar levels
|
US20050215640A1
(en)
|
2004-03-26 |
2005-09-29 |
Baxter Jeffrey H |
HMB compositions and uses thereof
|
JP4815752B2
(ja)
|
2004-04-01 |
2011-11-16 |
味の素株式会社 |
アミノ酸含有飲食品
|
WO2005110124A1
(en)
|
2004-04-15 |
2005-11-24 |
Abbott Laboratories |
Composition and methods for nutritional management of patients with hepatic disease
|
CN1582912A
(zh)
|
2004-06-10 |
2005-02-23 |
武汉启瑞科技发展有限公司 |
L-鸟氨酸和 l-门冬氨酸组合物
|
US20060002913A1
(en)
|
2004-06-22 |
2006-01-05 |
Gehlsen Kurt R |
Use of histamine and related compounds to treat disorders affecting muscle function
|
KR20120125993A
(ko)
|
2004-07-14 |
2012-11-19 |
아지노모토 가부시키가이샤 |
C형 간염 바이러스 양성 사람 간경변 환자용 간암 발생·진전 억제제
|
CN101018561A
(zh)
|
2004-07-19 |
2007-08-15 |
N·V·努特里奇亚 |
使用天冬氨酸和维生素b12或生物素调节酮体的制剂
|
EP1637163A1
(en)
|
2004-09-21 |
2006-03-22 |
Andreas Kluge |
Indicator of therapeutic compliance
|
JP5177785B2
(ja)
|
2004-11-02 |
2013-04-10 |
味の素株式会社 |
周術期患者用薬剤
|
US8389576B2
(en)
|
2004-11-26 |
2013-03-05 |
Ucl Business Plc |
Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
|
US20090048153A1
(en)
|
2004-12-03 |
2009-02-19 |
University Of Maryland, Baltimore |
Composition for treating sulfur mustard toxicity and methods of using same
|
WO2006061992A1
(ja)
|
2004-12-10 |
2006-06-15 |
Ajinomoto Co., Inc. |
肝疾患予防・治療用組成物
|
WO2006080086A1
(ja)
|
2005-01-31 |
2006-08-03 |
Takanobu Yamamoto |
中枢神経系の疲労回復又は疲労予防のための組成物
|
CN1679941A
(zh)
|
2005-02-02 |
2005-10-12 |
北京阜康仁生物制药科技有限公司 |
一种由牛磺酸和治疗肝病的药物组成的复方制剂及其制备方法
|
CA2537647A1
(en)
|
2005-03-01 |
2006-09-01 |
Six Star Formulations Ltd. |
Supplemental dietary composition for supporting muscle growth, recovery and strength
|
MX2007011264A
(es)
|
2005-03-15 |
2008-03-12 |
Nestec Sa |
Composiciones nutricionales para modular la biodisponibilidad de vitamina c.
|
BRPI0614016A2
(pt)
|
2005-03-21 |
2011-03-01 |
Abbott Lab |
composição de aminoácido para melhorar toleráncia à glicose
|
EP1865944B1
(en)
|
2005-03-29 |
2018-08-29 |
Ajinomoto Co., Inc. |
Amino acid-containing composition used for preventing or remedying decrease in skeletal muscle mass of aged people, comprising L-leucine
|
CN101175416A
(zh)
|
2005-04-06 |
2008-05-07 |
诺瓦提斯公司 |
从营养方面改善葡萄糖控制和胰岛素作用的方法和组合物
|
US8993627B2
(en)
|
2005-04-21 |
2015-03-31 |
Sentient Lifesciences, Inc. |
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
|
EP1890688A2
(en)
|
2005-06-14 |
2008-02-27 |
Nestec S.A. |
Nutritional method
|
JPWO2006137469A1
(ja)
|
2005-06-22 |
2009-01-22 |
味の素株式会社 |
代謝型グルタミン酸受容体活性化剤
|
US20100104548A1
(en)
|
2005-06-24 |
2010-04-29 |
Albert Einstein College Of Medicine Of Yeshiva University |
Modulation of amino acid metabolism in the hypothalamus
|
WO2007004613A1
(ja)
|
2005-07-01 |
2007-01-11 |
Ajinomoto Co., Inc. |
炎症性腸疾患治療薬及びTNF-α産生抑制剤
|
JP2007023921A
(ja)
*
|
2005-07-19 |
2007-02-01 |
Toyota Motor Corp |
内燃機関の制御装置
|
KR20080041675A
(ko)
|
2005-08-04 |
2008-05-13 |
아지노모토 가부시키가이샤 |
산화형 알부민 저하제
|
JP5067160B2
(ja)
|
2005-08-05 |
2012-11-07 |
味の素株式会社 |
肝癌発生・進展抑制剤
|
US8148356B2
(en)
|
2005-08-24 |
2012-04-03 |
Cumberland Pharmaceuticals, Inc. |
Acetylcysteine composition and uses therefor
|
JP5371429B2
(ja)
|
2005-08-26 |
2013-12-18 |
ネステク ソシエテ アノニム |
機能的な血管の完全性及び細胞生存を改善し、脳の虚血における又は虚血エピソード後のアポトーシスを減少するための組成物及び方法
|
EP1774973A1
(en)
|
2005-10-12 |
2007-04-18 |
Nutricia N.V. |
Leucine rich composition
|
CN101282657A
(zh)
|
2005-10-28 |
2008-10-08 |
雀巢技术公司 |
支链氨基酸的使用方法
|
WO2007056176A2
(en)
|
2005-11-03 |
2007-05-18 |
Southwest Immunology, Inc. |
Compositions for preventing and reducing delayed onset muscle soreness
|
MX2008005936A
(es)
|
2005-11-07 |
2008-10-01 |
Perque Llc |
Composiciones para regular trastornos metabolicos y metodos de uso de las mismas.
|
ES2363442T3
(es)
|
2005-11-30 |
2011-08-04 |
Nestec S.A. |
Combinación que comprende al menos una aminoácido y un inhibidor de pkr para utilizar en el tratamiento de la pérdida de masa muscular.
|
NZ568611A
(en)
|
2005-12-19 |
2011-11-25 |
Abbott Lab |
Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
|
CA2631220A1
(en)
|
2006-01-09 |
2007-07-19 |
Nestec S.A. |
Treatment of stressed patients
|
DK1983849T3
(da)
|
2006-01-20 |
2013-07-08 |
Innova Food Ab |
Fødevaresammensætning omfattende aminosyrer
|
WO2007088160A1
(en)
|
2006-01-31 |
2007-08-09 |
Nestec S.A. |
Nutritional composition for low birth weight infants
|
WO2007133642A1
(en)
|
2006-05-11 |
2007-11-22 |
Garcia Ramon D |
Sport drink containing amino acids and carbohydrates
|
JP5100033B2
(ja)
|
2006-05-16 |
2012-12-19 |
大塚製薬株式会社 |
消化管及び腎臓の萎縮抑制剤
|
US20070286909A1
(en)
|
2006-06-07 |
2007-12-13 |
Daniel S. Smith |
Amino acid compositions
|
JP2008050277A
(ja)
|
2006-08-22 |
2008-03-06 |
Ajinomoto Co Inc |
鉄欠乏性貧血症治療用組成物
|
US9192593B2
(en)
|
2006-08-30 |
2015-11-24 |
Ajinomoto Co., Inc. |
Amino-acid containing composition for inhibiting accumulation of fat
|
MX2009003778A
(es)
|
2006-10-19 |
2009-04-22 |
Nestec Sa |
Alimentacion a largo plazo para paciente de cancer.
|
US20080102137A1
(en)
|
2006-10-31 |
2008-05-01 |
Guffey Manning V R |
Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
|
GB0624879D0
(en)
|
2006-12-14 |
2007-01-24 |
Shs Int Ltd |
Treatment of pervasive development disorders
|
EP1932437A1
(en)
|
2006-12-15 |
2008-06-18 |
Nestec S.A. |
Infant formula
|
CN100518815C
(zh)
|
2007-02-15 |
2009-07-29 |
北京苏里曼医药科技有限公司 |
一种氨基酸组合物
|
US20080268038A1
(en)
|
2007-04-26 |
2008-10-30 |
Wolfe Robert R |
Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
|
CN101332209B
(zh)
|
2007-06-25 |
2010-12-08 |
三菱制药(广州)有限公司 |
治疗肝性脑病的复方氨基酸注射液
|
US8455531B2
(en)
|
2007-09-18 |
2013-06-04 |
Thermolife International, Llc |
Amino acid compositions
|
US7777074B2
(en)
|
2007-09-18 |
2010-08-17 |
Thermolife International, Llc |
Amino acid compounds
|
US8466187B2
(en)
|
2007-09-18 |
2013-06-18 |
Thermolife International, Llc |
Amino acid compositions
|
KR100970664B1
(ko)
|
2007-10-11 |
2010-07-15 |
한화제약주식회사 |
L-오르니틴-l-아스파테이트를 함유한 겔제의 제조방법 및그 겔제
|
EP2057905A1
(en)
|
2007-11-12 |
2009-05-13 |
TIMA Foundation |
Composition for moderating Triglyceride and Cholesterol Levels
|
US20110077198A1
(en)
|
2007-11-26 |
2011-03-31 |
Michael John Tisdale |
Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
|
CN101214050B
(zh)
|
2007-12-28 |
2011-08-31 |
叶高山 |
一种具有提神、抗疲劳、醒酒功能的保健饮料
|
ES2773928T5
(es)
|
2008-01-04 |
2023-06-28 |
Nestle Sa |
Composiciones que comprenden ácidos grasos insaturados y compuestos de liberación de óxido nítrico y uso de las mismas para la intensificación de las funciones cognitivas y relacionadas
|
US7790688B2
(en)
|
2008-01-11 |
2010-09-07 |
Healthspan Solutions, Llc |
Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
|
US20090186098A1
(en)
|
2008-01-18 |
2009-07-23 |
Jose Briceno |
Sports drink composition
|
EP2095728B1
(en)
|
2008-01-25 |
2011-09-07 |
Cesar Gallia s.r.l. |
Amino acid concentrate in aqueous gel and fatigue-relieving drink obtainable by diluting said concentrate in water
|
US8716249B2
(en)
|
2008-01-31 |
2014-05-06 |
Energy Light Llc |
Compositions and methods for improving cardiovascular health
|
JP2011514323A
(ja)
|
2008-02-05 |
2011-05-06 |
ヘルススパン ソリューションズ, エルエルシー |
高齢者の年齢関連性及び年齢特異的健康状態の管理のための治療的栄養を使用するシステム及び方法
|
RU2500406C2
(ru)
|
2008-02-07 |
2013-12-10 |
Нестек С.А. |
Композиции и способы влияния на восстановление после напряженной физической активности
|
EP2098126A1
(en)
|
2008-03-03 |
2009-09-09 |
Nestec S.A. |
Carbohydrate Bar
|
EP2098124A1
(en)
|
2008-03-03 |
2009-09-09 |
Nestec S.A. |
Carbohydrate gel
|
CN102316730A
(zh)
|
2008-05-09 |
2012-01-11 |
天雅瑞药业有限公司 |
用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
|
CA2727088A1
(en)
|
2008-06-04 |
2009-12-10 |
Phenolics, Llc |
Enteric-coated formulations of polyethylene glycol and one or more soluble amino acids for oral ingestion and enhanced uptake of same
|
US20100021573A1
(en)
*
|
2008-07-22 |
2010-01-28 |
Michael J Gonzalez |
Compositions and methods for the prevention of cardiovascular disease
|
WO2010033424A2
(en)
|
2008-09-19 |
2010-03-25 |
Nestec S.A. |
Nutritional support of the immune system during anti-cancer treatment
|
EP2165713B1
(en)
|
2008-09-19 |
2012-11-14 |
Nestec S.A. |
Whey and thymus function
|
EP2351562A4
(en)
|
2008-10-27 |
2012-09-05 |
Ajinomoto Kk |
SOLID SOLUTION OF VALIN, ISOLEUCIN AND LEUCIN AND MANUFACTURING PROCESS THEREFOR
|
US8362080B2
(en)
|
2008-12-18 |
2013-01-29 |
Baylor College Of Medicine |
Increasing glutathione levels for therapy
|
KR20170034928A
(ko)
|
2009-01-12 |
2017-03-29 |
바이오키어 인코포레이티드 |
당뇨병 치료 조성물 및 치료방법
|
US9314444B2
(en)
|
2009-01-12 |
2016-04-19 |
Biokier, Inc. |
Composition and method for treatment of NASH
|
WO2010108016A2
(en)
|
2009-03-18 |
2010-09-23 |
Healthspan Solutions, Llc |
Compositions and methods for sparing muscle in renal insufficiency and during hemodialysis
|
WO2010108542A1
(en)
|
2009-03-25 |
2010-09-30 |
Nestec S.A. |
A natural taste enhancing savoury base and a process for its preparation
|
ES2928586T3
(es)
|
2009-04-03 |
2022-11-21 |
Ocera Therapeutics Inc |
Fenilacetato de L-ornitina y métodos para elaborar el mismo
|
WO2010126353A1
(en)
|
2009-04-27 |
2010-11-04 |
N.V. Nutricia |
Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
|
US8703719B1
(en)
|
2009-05-18 |
2014-04-22 |
Bio-Engineered Supplements And Nutrition, Inc. |
Method and composition for improved muscle performance
|
EP2440200B8
(en)
|
2009-06-08 |
2014-10-15 |
UCL Business PLC |
Treatment of portal hypertension using l-ornithine phenylacetate
|
WO2010143939A1
(en)
|
2009-06-09 |
2010-12-16 |
N.V. Nutricia |
Nutrition for improving muscle strength in elderly
|
IN2012DN00486A
(es)
|
2009-07-20 |
2015-05-22 |
Nestec Sa |
|
WO2011030104A1
(en)
|
2009-09-09 |
2011-03-17 |
Rajiv Jalan |
Phenylacetate and/or phenylbutyrate (not ornithine) for reducing portal blood pressure
|
CN101664384B
(zh)
|
2009-09-18 |
2011-09-14 |
杭州市第六人民医院 |
N-乙酰半胱氨酸盐木糖醇注射液及其制备方法和应用
|
BR112012006437A2
(pt)
|
2009-09-23 |
2016-04-19 |
Biokier Inc |
composições e métodos para tratamento do diabetes e outros distúrbios
|
WO2011044230A2
(en)
|
2009-10-06 |
2011-04-14 |
Goldstein Glenn A |
N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions
|
WO2011043647A1
(en)
|
2009-10-09 |
2011-04-14 |
N.V. Nutricia |
Amino acid composition with improved dispersibility
|
EP2327316B1
(en)
|
2009-11-29 |
2016-11-16 |
Premier Nutrition Corporation |
Method of enhancing muscle protein synthesis
|
EP2327315B1
(en)
|
2009-11-29 |
2013-10-09 |
Nestec S.A. |
Dosing protocols for increasing protein synthesis in an active individual
|
JP2011132174A
(ja)
|
2009-12-24 |
2011-07-07 |
Kirin Holdings Co Ltd |
持久力向上剤
|
WO2011078654A1
(en)
|
2009-12-24 |
2011-06-30 |
N.V. Nutricia |
Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
|
WO2011097273A1
(en)
|
2010-02-02 |
2011-08-11 |
Martek Biosciences Corporation |
Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl lcystenine
|
CA2792396C
(en)
|
2010-03-12 |
2018-09-11 |
Nestec S.A. |
Compositions for masking the flavor of nutrients and methods for making same
|
WO2011119023A1
(en)
|
2010-03-26 |
2011-09-29 |
N.V. Nutricia |
Low protein infant formula with increased essential amino acids
|
CN103025178B
(zh)
|
2010-04-26 |
2015-02-11 |
雀巢产品技术援助有限公司 |
用于从胃肠外营养转换至肠内营养的营养组合物和方法
|
US8840950B2
(en)
|
2010-05-26 |
2014-09-23 |
Jacqueline M. Hibbert |
Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
|
WO2012005568A1
(en)
|
2010-07-07 |
2012-01-12 |
N.V. Nutricia |
Nutritional composition for the stimulation of muscle protein synthesis
|
KR101213825B1
(ko)
|
2010-07-16 |
2012-12-18 |
서울대학교산학협력단 |
세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물
|
MY173215A
(en)
|
2010-07-21 |
2020-01-06 |
Cumberland Pharmaceuticals Inc |
Acetylcysteine compositions and methods of use thereof
|
US20120020947A1
(en)
|
2010-07-22 |
2012-01-26 |
Northern Innovations And Formulations Corp. |
Compositions and methods for increasing lean muscle mass after exercise
|
CN101912394B
(zh)
|
2010-08-06 |
2013-11-06 |
岳茂兴 |
一种用于治疗凝血障碍出血的药物组合物及其用途
|
US8946473B2
(en)
|
2010-10-06 |
2015-02-03 |
Ocera Therapeutics, Inc. |
Methods of making L-ornithine phenyl acetate
|
EP2444083A1
(en)
|
2010-10-21 |
2012-04-25 |
Nestec S.A. |
Cysteine and food intake
|
EP2654462A1
(en)
|
2010-12-22 |
2013-10-30 |
Abbott Laboratories |
Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid
|
WO2012092035A1
(en)
|
2010-12-27 |
2012-07-05 |
Abbott Laboratories |
Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
|
WO2012097061A1
(en)
|
2011-01-13 |
2012-07-19 |
Abbott Laboratories |
Nutritional compositions and methods for improving skeletal muscle protein metabolism
|
AU2012209285B2
(en)
|
2011-01-25 |
2016-11-17 |
Nestec S. A. |
Methods and compositions for treating, reducing or preventing deterioration of the visual system of animals
|
RU2491062C2
(ru)
|
2011-03-16 |
2013-08-27 |
Общество С Ограниченной Ответственностью "Биотехнологии Пущино" |
Композиции протекторов острых и хронических печеночных энцелопатий и способ лечения острых и хронических печеночных энцелопатий
|
MX359453B
(es)
|
2011-03-18 |
2018-09-28 |
Nestec Sa |
Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad.
|
CN102327259A
(zh)
|
2011-03-31 |
2012-01-25 |
姜国辉 |
具有显著化学性肝损伤保护功能的复合生物制剂
|
US11235008B2
(en)
|
2011-03-31 |
2022-02-01 |
Ganeden Biotech, Inc. |
Probiotic sports nutrition compositions
|
CA2830970A1
(en)
|
2011-04-12 |
2012-10-18 |
Nestec S.A. |
Nutritional compositions including branched chain fatty acids and methods of using same
|
EP2699110A1
(en)
|
2011-04-18 |
2014-02-26 |
Nestec S.A. |
Nutritional compositions having alpha-hica and alpha-ketoglutarate
|
US20120270860A1
(en)
|
2011-04-19 |
2012-10-25 |
Gihyun Yoon |
Methods for treating or preventing alcohol-related disorders or craving-related disorders
|
CA2831798A1
(en)
|
2011-04-21 |
2012-10-26 |
Nestec S.A. |
Nutritional compositions for enhancing performance and methods for making and using same
|
US8828426B2
(en)
|
2011-06-07 |
2014-09-09 |
Zx Pharma, Llc |
Multiparticulate L-carnitine compositions and related methods
|
WO2013006658A1
(en)
|
2011-07-05 |
2013-01-10 |
The Brigham And Women's Hospital, Inc. |
Treatment of acetaminophen-induced liver damage by the administration of modulators of nitric oxide
|
BR112014002779A2
(pt)
|
2011-08-08 |
2017-02-21 |
Ajinomoto Kk |
composição contendo aminoácido para o melhoramento da recuperação a partir de fadiga muscular
|
CA2845829A1
(en)
|
2011-08-19 |
2013-02-28 |
Musclepharm Corporation |
Compositions and methods for use in promoting lean body mass
|
EP2574333B1
(en)
|
2011-09-27 |
2017-01-11 |
Friulchem SpA |
N-acetylcysteine effervescent tablet and its therapeutical applications
|
EP2580967A1
(en)
|
2011-10-11 |
2013-04-17 |
Nestec S.A. |
Accelerating muscle recovery after immobilization-induced muscle atrophy
|
EP2583565A1
(en)
|
2011-10-21 |
2013-04-24 |
Nestec S.A. |
Use of whey protein micelles for enhancing energy expenditure and satiety
|
EP2583563A1
(en)
|
2011-10-21 |
2013-04-24 |
Nestec S.A. |
Whey protein micelles against muscle atrophy and sarcopenia
|
WO2013075095A1
(en)
|
2011-11-18 |
2013-05-23 |
The Board Of Trustees Of The University Of Arkansas |
Use of amino acid supplementation for improved muscle recovery
|
EP3437649A1
(en)
|
2011-11-21 |
2019-02-06 |
Emmaus Medical Inc. |
Methods and compositions for the treatment of diabetes and related symptoms
|
KR101909433B1
(ko)
|
2011-12-02 |
2018-10-18 |
고쿠리츠다이가쿠호우진 야마구치 다이가쿠 |
키나제 저해제의 부작용 저감제
|
US20150004202A1
(en)
|
2012-01-19 |
2015-01-01 |
Shoichi Shirotake |
Antibacterial agent against plant disease-causing bacteria
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
US20150119339A1
(en)
|
2012-06-11 |
2015-04-30 |
Abbott Laboratories |
Use of hmb to improve health outcomes for hospitalized patients
|
WO2014020004A1
(en)
|
2012-07-31 |
2014-02-06 |
Nestec S.A. |
Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (ibd)
|
US20150223501A1
(en)
|
2012-09-14 |
2015-08-13 |
Nestec S.A. |
Novel flavour compositions with improved flavour and/or flavour shelf-life
|
US9198889B2
(en)
|
2012-09-19 |
2015-12-01 |
Quality IP Holdings, LLC |
Methods for treating post-traumatic stress disorder
|
US8747921B2
(en)
|
2012-09-19 |
2014-06-10 |
Quality Ip Holdings, Inc. |
Methods for improving health in humans
|
US9066953B2
(en)
|
2012-09-20 |
2015-06-30 |
Quality IP Holdings, LLC |
Methods for increasing endurance and fat metabolism in humans
|
CN102961377A
(zh)
|
2012-11-08 |
2013-03-13 |
湖北一半天制药有限公司 |
复方氨基酸注射液(20aa)的制备方法
|
US9410963B2
(en)
|
2012-12-04 |
2016-08-09 |
Nestec S.A. |
Hexanoylglycine as biomarker for the predisposition for weight gain and obesity
|
US10064900B2
(en)
|
2013-02-04 |
2018-09-04 |
Seres Therapeutics, Inc. |
Methods of populating a gastrointestinal tract
|
US10350185B2
(en)
|
2013-03-11 |
2019-07-16 |
University Of Florida Research Foundation, Incorporated |
Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
|
RU2015143836A
(ru)
|
2013-03-15 |
2017-04-27 |
Нусерт Сайенсиз, Инк. |
Лейцин и никотиновая кислота для снижения уровня липидов
|
CA2907667A1
(en)
|
2013-03-26 |
2014-10-02 |
Premier Nutrition Corporation |
Methods for enhancing muscle protein synthesis following concurrent training
|
BR112015025490B1
(pt)
|
2013-04-15 |
2022-05-03 |
Société des Produits Nestlé S.A. |
Uso de uma fonte de aminoácidos em combinação com o estímulo muscular elétrico
|
AU2014254147A1
(en)
|
2013-04-16 |
2015-12-03 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the treatment of brain injury
|
US20140357576A1
(en)
|
2013-05-31 |
2014-12-04 |
Nestec S.A. |
Methods for enhancement of muscle protein synthesis
|
PL3019024T3
(pl)
|
2013-06-28 |
2017-07-31 |
Nestec S.A. |
Kompozycje i sposoby do zwiększania wydolności podczas wysiłku fizycznego
|
EP3738590A1
(en)
|
2013-07-31 |
2020-11-18 |
Leeds Beckett University |
Dietary supplement comprising amino acids for the treatment of sarcopenia
|
RU2016110800A
(ru)
|
2013-09-25 |
2017-10-30 |
Пронутриа Биосайенсис, Инк. |
Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
|
US20180125926A1
(en)
|
2013-09-25 |
2018-05-10 |
Axcella Health Inc. |
Compositions and Formulations and Methods of Production and Use Thereof
|
CA2923705C
(en)
|
2013-10-09 |
2024-05-14 |
Nestec S.A. |
Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
|
WO2015061607A1
(en)
|
2013-10-23 |
2015-04-30 |
Whitehead Institute For Biomedical Research |
Mtorc1 modulation by amino acids and uses thereof
|
SG11201607075TA
(en)
|
2014-02-27 |
2016-09-29 |
Nusirt Sciences Inc |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
GB2523578A
(en)
|
2014-02-28 |
2015-09-02 |
Daniel Nelson |
A nutritional supplement
|
WO2015161448A1
(en)
|
2014-04-22 |
2015-10-29 |
Wuhan Ll Science And Technology Development Co., Ltd. |
Ornithine-containing or aspartate-containing compositions and the uses thereof
|
CN105092753B
(zh)
|
2014-05-20 |
2016-09-07 |
中国科学院大连化学物理研究所 |
组合型胺类代谢标志物的应用及试剂盒
|
WO2016003263A1
(en)
|
2014-07-01 |
2016-01-07 |
N.V. Nutricia |
Amino acid based diet with improved taste
|
US10217645B2
(en)
|
2014-07-25 |
2019-02-26 |
Versum Materials Us, Llc |
Chemical mechanical polishing (CMP) of cobalt-containing substrate
|
US20160158305A1
(en)
|
2014-09-19 |
2016-06-09 |
Chip E. Thomson |
Additives and supplements
|
WO2016058919A1
(en)
|
2014-10-14 |
2016-04-21 |
Nestec S.A. |
Improvement in muscle functionality of elderly males
|
WO2016085887A1
(en)
|
2014-11-24 |
2016-06-02 |
Ucl Business Plc |
Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies
|
MX368900B
(es)
|
2014-12-04 |
2019-10-21 |
Professional Dietetics Spa |
Composicion a base de aminoacidos para recuperacion de fibroelastina en tejidos conectivos dermicos.
|
WO2016094316A1
(en)
|
2014-12-08 |
2016-06-16 |
Synaptamine, Inc. |
Anti-rds compounds and method of manufacture and administration thereof to induce dopamine homeostatis
|
EP3034074A1
(en)
|
2014-12-18 |
2016-06-22 |
Universitat De València, Estudi General |
Compound for treatment of myotonic dystrophy type 1
|
JP6959136B2
(ja)
|
2015-01-23 |
2021-11-02 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
患者の示差的な栄養所要量の決定方法
|
WO2016116585A1
(en)
|
2015-01-23 |
2016-07-28 |
Nestec S.A. |
Promotion of healing of intestinal mucosa using proline, serine and threonine
|
US10137108B2
(en)
|
2015-01-23 |
2018-11-27 |
Nestec S.A. |
Nutritional composition useful in the treatment of IBD patients
|
CN107106528A
(zh)
|
2015-01-23 |
2017-08-29 |
雀巢产品技术援助有限公司 |
使用丝氨酸治疗或预防炎症
|
WO2016121829A1
(ja)
|
2015-01-27 |
2016-08-04 |
昇一 城武 |
ナノ粒子を有効成分とする皮膚炎の治療又は予防剤
|
WO2016128576A1
(en)
|
2015-02-13 |
2016-08-18 |
Nestec S.A. |
Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory cytokines
|
US20180036270A1
(en)
|
2015-02-13 |
2018-02-08 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
A method of protecting against carbonyl stress induced ischemia-reperfusion injury in the diabetic brain via administration of n-acetylcysteine
|
FR3032883B1
(fr)
*
|
2015-02-24 |
2017-03-17 |
International Nutrition Res Company |
Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
|
US20160302451A1
(en)
|
2015-04-16 |
2016-10-20 |
Michael Hudnall |
Medical Food for Patients with Chronic Liver Disease
|
US20160338982A1
(en)
|
2015-04-20 |
2016-11-24 |
Ocera Therapeutics, Inc. |
Formulations of l-ornithine phenylacetate
|
US10123985B2
(en)
|
2015-06-08 |
2018-11-13 |
Whitehead Institute For Biomedical Research |
Therapeutic strategies for treating mitochondrial disorders
|
CN107708446A
(zh)
|
2015-06-22 |
2018-02-16 |
雀巢产品技术援助有限公司 |
用于增强动物体内神经形成的组合物和方法
|
MX2017016467A
(es)
|
2015-06-30 |
2018-05-17 |
Nestec Sa |
Composicion adecuada para proteger microorganismos.
|
CA2991768C
(en)
|
2015-07-15 |
2023-03-21 |
Unigen, Inc. |
Compositions, methods, and medical compositions for treatment of and maintaining the health of the liver
|
JP7008015B2
(ja)
|
2015-08-14 |
2022-01-25 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
ソフトな質感を維持するセミモイストフード組成物
|
JP6990170B2
(ja)
|
2015-08-18 |
2022-01-12 |
オセラ セラピューティクス, インコーポレイテッド |
L-オルニチンをフェニルアセテートおよびフェニルブチレートのうちの少なくとも1つと組み合わせて用いる筋肉喪失の治療および予防
|
US11019817B2
(en)
|
2015-08-25 |
2021-06-01 |
Shoichi Shirotake |
Antimicrobial agent against germs which has excellent plant disease control effect
|
US20170079897A1
(en)
|
2015-09-20 |
2017-03-23 |
Matthew Brissette MINUS |
Composition for hair application and methods of hair care
|
US20200206174A1
(en)
|
2015-09-25 |
2020-07-02 |
Ocera Therapeutics, Inc. |
Treatment and prevention of neuronal cell loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
|
US20170196944A1
(en)
|
2015-09-28 |
2017-07-13 |
Robert Portman |
Method to reduce muscle atrophy following orthopedic surgery
|
CN108366983A
(zh)
|
2015-11-13 |
2018-08-03 |
欧塞拉治疗有限公司 |
L-鸟氨酸苯乙酸盐制剂
|
US11219611B2
(en)
|
2015-11-13 |
2022-01-11 |
Ocera Therapeutics, Inc. |
Formulations of L-ornithine phenylacetate
|
BR112018008186B1
(pt)
|
2015-11-20 |
2021-11-23 |
Société des Produits Nestlé S.A. |
Composição que compreende micelas de proteína de soro de leite, e seus usos
|
CH713469B1
(de)
|
2015-12-21 |
2021-06-30 |
Nianjing Jianrong Bio Tech Co Ltd |
Zusammensetzung zum Behandeln von Motoneuron-Erkrankungen
|
EA201891592A1
(ru)
|
2016-01-08 |
2019-02-28 |
КОЛОНАРИКОНСЕПТС ЭлЭлСи |
Основанная на пищевых продуктах доставка терапевтического агента для лечения печеночной энцефалопатии
|
GB201600990D0
(en)
|
2016-01-19 |
2016-03-02 |
Abbott Lab |
Pharmaceutical or nutritional combination
|
US20190133147A1
(en)
|
2016-05-11 |
2019-05-09 |
Tsubo Solutions Pty Ltd |
Confectionery product
|
WO2017202939A1
(en)
|
2016-05-27 |
2017-11-30 |
Nestec S.A. |
Nutritional composition for treating or preventing impaired mobility
|
PL238958B1
(pl)
|
2016-06-29 |
2021-10-25 |
Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia |
Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
|
US20180015122A1
(en)
|
2016-07-14 |
2018-01-18 |
Companion Supplements, LLC |
Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
|
US11033522B2
(en)
|
2016-08-09 |
2021-06-15 |
David C Scott |
Free amino acid preparation and uses thereof
|
JOP20190147A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
SE540582C2
(en)
|
2016-12-22 |
2018-10-02 |
Scandibio Therapeutics Ab |
Substances for treatment of fatty liver-related conditions
|
CN106632605B
(zh)
|
2016-12-22 |
2020-06-16 |
浙江海洋大学 |
利用金枪鱼下脚料制备的具有肝损伤修复作用的活性肽
|
EP3570826A4
(en)
|
2017-01-19 |
2020-09-23 |
Otologic Pharmaceutics, Inc. |
N-ACETYLCYSTEIN FORMULATIONS AND THEIR USES
|
EP3615018A1
(en)
|
2017-04-28 |
2020-03-04 |
Axcella Health Inc. |
Amino acid compositions and their use for the treatment of traumatic brain injury
|
CN107242552A
(zh)
|
2017-07-07 |
2017-10-13 |
上海东锦食品集团有限公司 |
具有缓解体力疲劳及增强免疫力功能的保健食品组合物
|
WO2019036442A1
(en)
|
2017-08-14 |
2019-02-21 |
Axcella Health Inc. |
AMINO ACIDS BRANCHED FOR THE TREATMENT OF NEURONAL INJURY
|
MA49906A
(fr)
|
2017-08-14 |
2020-06-24 |
Axcella Health Inc |
Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
|
CN108041501A
(zh)
|
2017-12-22 |
2018-05-18 |
北京康比特体育科技股份有限公司 |
一种促进疲劳恢复的蛋白组合物及其制备方法
|
WO2019246310A1
(en)
|
2018-06-20 |
2019-12-26 |
Axcella Health Inc. |
Compositions and methods for the reduction or treatment of inflammation
|
JP2021527670A
(ja)
|
2018-06-20 |
2021-10-14 |
アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. |
筋肉中の脂肪浸潤の治療のための組成物及び方法
|
CN112839708A
(zh)
|
2018-06-20 |
2021-05-25 |
胺细拉健康公司 |
用于减少或治疗纤维化的组合物和方法
|
WO2019246221A1
(en)
|
2018-06-20 |
2019-12-26 |
Axcella Health Inc. |
Compositions and methods for the treatment of liver diseases and disorders
|
CU20200106A7
(es)
|
2018-06-20 |
2021-08-06 |
Axcella Health Inc |
Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
|
WO2019246299A1
(en)
|
2018-06-20 |
2019-12-26 |
Axcella Health Inc. |
Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditions
|
WO2019246256A1
(en)
|
2018-06-20 |
2019-12-26 |
Axcella Health Inc. |
Compositions for therapy and health containing amino acids with bitter taste
|
EP3810168A1
(en)
|
2018-06-20 |
2021-04-28 |
Axcella Health Inc. |
Methods of manufacturing amino acid compositions
|
CN108524453A
(zh)
|
2018-07-05 |
2018-09-14 |
扬子江药业集团广州海瑞药业有限公司 |
一种门冬氨酸鸟氨酸的药物组合物
|